Suppr超能文献

组氨酸丰富糖蛋白诱导的血管正常化可改善 EPR 介导的药物靶向肿瘤及进入肿瘤。

Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors.

机构信息

Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands.

Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany.

出版信息

J Control Release. 2018 Jul 28;282:25-34. doi: 10.1016/j.jconrel.2018.05.002. Epub 2018 May 4.

Abstract

Tumors are characterized by leaky blood vessels, and by an abnormal and heterogeneous vascular network. These pathophysiological characteristics contribute to the enhanced permeability and retention (EPR) effect, which is one of the key rationales for developing tumor-targeted drug delivery systems. Vessel abnormality and heterogeneity, however, which typically result from excessive pro-angiogenic signaling, can also hinder efficient drug delivery to and into tumors. Using histidine-rich glycoprotein (HRG) knockout and wild type mice, and HRG-overexpressing and normal t241 fibrosarcoma cells, we evaluated the effect of genetically induced and macrophage-mediated vascular normalization on the tumor accumulation and penetration of 10-20 nm-sized polymeric drug carriers based on poly(N-(2-hydroxypropyl)methacrylamide). Multimodal and multiscale optical imaging was employed to show that normalizing the tumor vasculature improves the accumulation of fluorophore-labeled polymers in tumors, and promotes their penetration out of tumor blood vessels deep into the interstitium.

摘要

肿瘤的特征是血管渗漏,以及异常和异质的血管网络。这些病理生理特征有助于增强通透性和保留(EPR)效应,这是开发肿瘤靶向药物传递系统的关键原理之一。然而,血管异常和异质性通常是由于过度的促血管生成信号引起的,也会阻碍药物有效递送到和进入肿瘤。使用组氨酸丰富糖蛋白(HRG)敲除和野生型小鼠,以及 HRG 过表达和正常 t241 纤维肉瘤细胞,我们评估了遗传诱导和巨噬细胞介导的血管正常化对基于聚(N-(2-羟丙基)甲基丙烯酰胺)的 10-20nm 大小的聚合物药物载体在肿瘤中的积累和渗透的影响。采用多模态和多尺度光学成像表明,使肿瘤血管正常化可改善荧光标记聚合物在肿瘤中的积累,并促进其从肿瘤血管中渗透到间质深处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d156/6130770/ae9b69639331/emss-79419-f001.jpg

相似文献

引用本文的文献

本文引用的文献

2
Rethinking cancer nanotheranostics.重新思考癌症纳米诊疗学
Nat Rev Mater. 2017;2. doi: 10.1038/natrevmats.2017.24. Epub 2017 May 9.
6
Enhancing Tumor Penetration of Nanomedicines.增强纳米药物的肿瘤渗透能力。
Biomacromolecules. 2017 May 8;18(5):1449-1459. doi: 10.1021/acs.biomac.7b00068. Epub 2017 Mar 31.
8
Role of vascular normalization in benefit from metronomic chemotherapy.血管正常化在节律性化疗获益中的作用。
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):1994-1999. doi: 10.1073/pnas.1700340114. Epub 2017 Feb 7.
10
Cancer nanomedicine: Is targeting our target?癌症纳米医学:我们瞄准的是目标吗?
Nat Rev Mater. 2016 Sep;1(9). doi: 10.1038/natrevmats.2016.69. Epub 2016 Sep 7.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验